Copyright
©The Author(s) 2022.
World J Gastroenterol. Apr 21, 2022; 28(15): 1563-1573
Published online Apr 21, 2022. doi: 10.3748/wjg.v28.i15.1563
Published online Apr 21, 2022. doi: 10.3748/wjg.v28.i15.1563
Figure 1 Flow diagram of the study population.
NAFLD: Nonalcoholic fatty liver disease; FIB-8: Fibrosis-8 score; FIB-4: Fibrosis-4 score; NFS: NAFLD fibrosis score; AASLD: American Association for the Study of Liver Diseases; GGT: Gamma-glutamyl transferase.
Figure 2 Receiver operating characteristic curves of the fibrosis-8 score, fibrosis-4 score, and nonalcoholic fatty liver disease fibrosis score for predicting significant fibrosis (F ≥ 2) in the Asian population (n = 511).
NAFLD: Nonalcoholic fatty liver disease; FIB-8: Fibrosis-8 score; FIB-4: Fibrosis-4 score; NFS: NAFLD fibrosis score; AUROC: Areas under the receiver operating characteristic curves.
- Citation: Prasoppokakorn T, Chan WK, Wong VWS, Pitisuttithum P, Mahadeva S, Nik Mustapha NR, Wong GLH, Leung HHW, Sripongpun P, Treeprasertsuk S. Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease . World J Gastroenterol 2022; 28(15): 1563-1573
- URL: https://www.wjgnet.com/1007-9327/full/v28/i15/1563.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i15.1563